FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285412529> ?p ?o ?g. }

• W4285412529 endingPage "428" @default.
• W4285412529 startingPage "428" @default.
• W4285412529 abstract "Sir, Psychedelic studies have reported positive results for depression and anxiety related to cancer and other life-threatening illnesses, treatment-resistant depression, and tobacco and alcohol dependence.[1] Although there are no active psychedelic research studies going on in India, there is growing interest about these substances as evident by numerous social media groups and pages with a lot of active members. Studies regarding psychedelic use in the Indian population are hard to find. To look into the current pattern of use of psychedelics in India and user subjective experiences, an online survey was carried out over a 6-month period from August 15, 2020 using Google forms. Information about the study to participants was given via social media platforms. Participants were encouraged to share the questionnaire among their colleagues and friends. Online questionnaire contained questions containing sociodemographic details such as age, sex, education, occupation, religion, and so on. Questions regarding psychedelic use including the type of substances used, frequency, reasons for use, and so on were included in the second part. To assess participants’ subjective experiences and their spiritual significance, Mystical experience questionnaire (MEQ) 30 item version was used.[2] The Challenging experience questionnaire (CEQ) was used to assess difficulty during psychedelic experience.[3] DSM IV TR criteria were used to rule out hallucinogen persisting perception disorder.[45] Out of the 68 responses received from the survey, 49 were included in the study. Lysergic acid diethylamide (LSD) (93.9%, n = 46) remained popular among the users, followed by Psilocybin mushrooms (75.5%, n = 37) and N, N-dimethyltryptamine (36.7%, n = 18). The majority (75.5%, n = 34) has stated LSD as the first psychedelic they have used. For the rest, the first psychedelic was Psilocybin mushrooms. The mean age at the first psychedelic use was 22.42 ± (2.99). 75.5% (n = 37) have looked up about the substance before using it. Main reasons for trying psychedelics for the first few times were personality development 38.7% (n = 19), just out of curiosity 36.7% (n = 18), and meditation/spiritual reasons 30.6% (n = 15). The majority of the participants considered their first psychedelic experience positively. On our question about their preference of taking psychedelics, 38.8% preferred to take as a group in nature. This was followed by Alone in nature (26.5%), Parties (14.3%), Alone - indoors (12.2%), and Group – Indoors (8.16%). The mean total score of MEQ was 117 (out of 150), which implied that the majority had an experience which can only be described as mystical. Out of the 30 items scored out of 5, Experience of amazement (4.43), Sense that the experience cannot be described adequately in words (4.41), Sense of awe or awesomeness (4.35), Feelings of joy (4.31), Experience of ecstasy (4.14), Experience of oneness or unity with the objects and/or persons perceived in your surroundings (4.10), and Certainty of encounter with ultimate reality (4.10) got more positive responses. Acute adverse reactions otherwise known as “bad trips” are common when the substances are used in an uncontrolled setting. To know more about these experiences, participants were asked to take CEQ. On individual items, Feeling my heart beating (2.85), I felt like crying (2.46), Feeling of isolation from people and things (2.32), I had the profound experience of my own death (2.29), and I had the feeling something horrible would happen (2.21) got higher average scores compared to others. These findings were in line with previous psychedelic studies.[1] Figure 1 and 2 describes percentage of maximum possible score of mean score and subscales of MEQ30 and CEQ respectively. The occurrence of hallucinogenic post-perception disorder in our sample was 4.08% (n = 2). Although very few satisfied the criteria, many of the participants experienced perceptual abnormalities following the use of psychedelics.Figure 1: Percentage of maximum possible score of mean score and subscales of MEQ30Figure 2: Percentage of maximum possible score of mean score and subscales of CEQWhile conducting the survey, we felt that the established structured questionnaires used for analyzing subjective experience might not be the best that we can use in an Indian setting. Because it is a less researched area, especially in India, this warrants more well-structured qualitative studies among psychedelic users to look into their subjective experience and development of better structural tools considering the socio-cultural differences. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest." @default.
• W4285412529 created "2022-07-14" @default.
• W4285412529 creator A5004589869 @default.
• W4285412529 date "2022-01-01" @default.
• W4285412529 modified "2023-10-14" @default.
• W4285412529 title "Psychedelic use in India, its pattern and personal significance – findings from an online survey" @default.
• W4285412529 cites W2024490100 @default.
• W4285412529 cites W2129290879 @default.
• W4285412529 cites W2549202270 @default.
• W4285412529 cites W4211211437 @default.
• W4285412529 doi "https://doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_447_21" @default.
• W4285412529 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36060724" @default.
• W4285412529 hasPublicationYear "2022" @default.
• W4285412529 type Work @default.
• W4285412529 citedByCount "0" @default.
• W4285412529 crossrefType "journal-article" @default.
• W4285412529 hasAuthorship W4285412529A5004589869 @default.
• W4285412529 hasBestOaLocation W42854125291 @default.
• W4285412529 hasConcept C118552586 @default.
• W4285412529 hasConcept C124315065 @default.
• W4285412529 hasConcept C126322002 @default.
• W4285412529 hasConcept C144133560 @default.
• W4285412529 hasConcept C15744967 @default.
• W4285412529 hasConcept C162853370 @default.
• W4285412529 hasConcept C169760540 @default.
• W4285412529 hasConcept C170493617 @default.
• W4285412529 hasConcept C17744445 @default.
• W4285412529 hasConcept C199539241 @default.
• W4285412529 hasConcept C26760741 @default.
• W4285412529 hasConcept C2775864247 @default.
• W4285412529 hasConcept C2776502132 @default.
• W4285412529 hasConcept C2779871769 @default.
• W4285412529 hasConcept C2908647359 @default.
• W4285412529 hasConcept C518677369 @default.
• W4285412529 hasConcept C558461103 @default.
• W4285412529 hasConcept C65067816 @default.
• W4285412529 hasConcept C70410870 @default.
• W4285412529 hasConcept C71924100 @default.
• W4285412529 hasConcept C99454951 @default.
• W4285412529 hasConceptScore W4285412529C118552586 @default.
• W4285412529 hasConceptScore W4285412529C124315065 @default.
• W4285412529 hasConceptScore W4285412529C126322002 @default.
• W4285412529 hasConceptScore W4285412529C144133560 @default.
• W4285412529 hasConceptScore W4285412529C15744967 @default.
• W4285412529 hasConceptScore W4285412529C162853370 @default.
• W4285412529 hasConceptScore W4285412529C169760540 @default.
• W4285412529 hasConceptScore W4285412529C170493617 @default.
• W4285412529 hasConceptScore W4285412529C17744445 @default.
• W4285412529 hasConceptScore W4285412529C199539241 @default.
• W4285412529 hasConceptScore W4285412529C26760741 @default.
• W4285412529 hasConceptScore W4285412529C2775864247 @default.
• W4285412529 hasConceptScore W4285412529C2776502132 @default.
• W4285412529 hasConceptScore W4285412529C2779871769 @default.
• W4285412529 hasConceptScore W4285412529C2908647359 @default.
• W4285412529 hasConceptScore W4285412529C518677369 @default.
• W4285412529 hasConceptScore W4285412529C558461103 @default.
• W4285412529 hasConceptScore W4285412529C65067816 @default.
• W4285412529 hasConceptScore W4285412529C70410870 @default.
• W4285412529 hasConceptScore W4285412529C71924100 @default.
• W4285412529 hasConceptScore W4285412529C99454951 @default.
• W4285412529 hasIssue "4" @default.
• W4285412529 hasLocation W42854125291 @default.
• W4285412529 hasLocation W42854125292 @default.
• W4285412529 hasLocation W42854125293 @default.
• W4285412529 hasOpenAccess W4285412529 @default.
• W4285412529 hasPrimaryLocation W42854125291 @default.
• W4285412529 hasRelatedWork W1856952423 @default.
• W4285412529 hasRelatedWork W1961057301 @default.
• W4285412529 hasRelatedWork W1983574733 @default.
• W4285412529 hasRelatedWork W2048153341 @default.
• W4285412529 hasRelatedWork W2129427539 @default.
• W4285412529 hasRelatedWork W2748952813 @default.
• W4285412529 hasRelatedWork W3132514504 @default.
• W4285412529 hasRelatedWork W3136293367 @default.
• W4285412529 hasRelatedWork W4292370110 @default.
• W4285412529 hasRelatedWork W4386021261 @default.
• W4285412529 hasVolume "64" @default.
• W4285412529 isParatext "false" @default.
• W4285412529 isRetracted "false" @default.
• W4285412529 workType "article" @default.